Ernst & Young
Fraud Investigation & Dispute Services, Life Sciences
Tighter competition, regulatory scrutiny and tough enforcement heighten the risk of litigation and non-compliance. In your industry, compliance issues and risk factors need to be addressed at every turn, from research and development to marketing strategies and supply chain integrity. And the scrutiny of regulators and customers alike is increasing and rapidly changing.

EY professionals understand the complex issues facing pharmaceutical, biotechnology and medical device companies. We have significant experience helping companies evaluate and manage those aspects of their businesses that pose the greatest potential risks. Our dedicated teams include CPAs, government contract analysts, economists, licensed pharmacists and certified fraud examiners, as well as former pharmaceutical executives, ethics and compliance officers and government auditors, investigators and prosecutors.

For more information visit www.ey.com or contact: Ted Acosta, Principal, Fraud Investigation & Dispute Services, Ernst & Young LLP (212) 773-3022.

PwC Global Pharmaceuticals and Life Sciences Industry Group
The Global Pharmaceuticals and Life Sciences Industry Group at PwC is dedicated to delivering effective solutions to the complex business challenges facing pharmaceutical and life sciences companies. A global leader in serving the pharmaceutical and life sciences industry, PwC has extensive experience working with companies on industry-specific strategic, operational, and financial issues. Our capabilities include assurance, tax and advisory services, as well as industry specialised services in regulatory compliance, risk management, and transaction support. In helping our clients, we draw on the full knowledge and skills of PwC's professionals. More than 200,000 people in 157 countries connect their thinking, experience and solutions to build public trust and enhance value for clients and their stakeholders.

For more information, visit www.pwc.com/pharma.

Baker & McKenzie
Baker & McKenzie's involvement in the pharmaceutical, healthcare and medical industry stretches over 50 years. Our global team of more than 450 lawyers with deep experience in local regulatory processes and laws affecting pharmaceutical, medical device and biotechnology businesses, helps healthcare companies stay ahead in established markets and gain ground in new ones.

Baker & McKenzie has a legal network spanning 75 locations in 47 countries. Across our 15 offices in Latin America, we provide a wide range of compliance advice and assistance, including in relation to: anticorruption, trade sanctions and export controls, customs, antitrust, data protection, environmental, healthcare marketing and promotional law, and strategic advice in government investigations and enforcement proceedings. In the area of global compliance, we provide integrated counsel to ensure consistency across borders and markets.

For more information, please visit www.bakermckenzie.com, or contact Dianne Phoebus, Chair Latin America Pharmaceuticals & Healthcare Industry Groups, +58 212 276 5177.

Davis Wright Tremaine
Those of us in the Davis Wright Tremaine health care practice group devote nearly all of our time to industry-specific matters. This allows us to develop niche practices within the field that serve needs unique to the health care market. We also understand the business issues and regulatory developments that affect health care delivery and compliance, and as a unified team we can match the attorney with the niche expertise that best addresses client needs. For more information visit our website at www.DWT.com.

Porzio Life Sciences, LLC
Porzio Life Sciences, LLC (PorzioLS) provides the life science industry with Internet-based products enabling companies to comply with marketing and sales federal and state laws and regulations, as well as, distribution licensing, sampling and a growing body of state life science compliance requirements. PorzioLS provides compliance tools and customized services, related to the PDMA, anti-kickback statutes, aggregate spend reporting, OIG and CMS guidances, OPDP promotional violations, False Claims Act and FDA regulations, such as the Porzio Compliance Digest and Porzio AggregateSpendID, a best in class aggregate spend system capable of handling state and federal transparency reporting and dispute resolutions, in addition to sample transparency reporting.

Porzio AggregateSpendID streamlines state and federal marketing disclosures by automating the collection and accurate reporting of expenses directed to healthcare practitioners and organizations. The searchable databases of the Porzio Compliance Digest cover drug and device distribution licensing, transparency legislation, sample and trade product distribution, and trends in government investigations.

Through our Distribution Licensing Services, we identify and attain all required licenses based on a company's unique distribution model. Finally, our formula-based approach to sample accountability, Significant Loss Threshold Assurance, ensures that customers neither over or under report sample losses. These compliance tools and customized services facilitate companies' compliance with federal and state marketing and sales regulations, which has propelled PorzioLS into an industry leader in life science marketing and sales compliance.

The International Life Sciences Transparency Database provides guidance on non-US disclosure requirements pertaining to interactions with HCPs and HCOs and provides easy-to-read excerpts and summaries (in English) on crucial global information including, non-US reporting requirements concerning HCP/HCO transfers of value, anti-bribery and anti-corruption, prohibitions and financial limitations on HCP/HCO interactions and data privacy. The International Database also contains EFPIA, Eucomed, IFPMA and Mecomed international industry and member association codes.

Strengthen your compliance program today by visiting www.porziolifesciences.com or contacting us 877-477-7411.

Sidley Austin
Sidley Austin LLP is a premier law firms with an internationally recognized life sciences practice, representing large to start-ups pharmaceutical, biotechnology, medical device, dietary supplements and food clients. Many lawyers in our team are acknowledged leaders in regulatory, compliance, enforcement, FCPA/Anticorruption, M&A and other areas. Sidley consistently ranks among the top firms in Asia, Europe and the U.S., and recently was named "Life Cycle: Firm of the Year" by LMG Life Sciences Awards 2013. Sidley is also recognized for service and responsiveness, having been once named the "Most Recommended Law Firm in the Pharmaceutical Industry" in the BTI Industry Power Rankings. For more information visit www.Sidley.com or contact Scott Bass, (202)736-8684 and James Stansel, (202) 736-8092.

Skadden, Arps, Slate, Meagher & Flom LLP
With approximately 1,800 attorneys in 22 offices on five continents, Skadden represents a broad range of clients in all sectors of the health care industry. Skadden represents pharmaceutical and medical technology clients at every stage of a company's development, from initial public offering to global M&A and corporate finance, and all manner of litigation and regulatory matters, including government investigations, mass torts and product liability litigation, intellectual property counseling and patent litigation, and FDA and healthcare compliance. Skadden has assisted many companies in developing and implementing global anti-bribery and anti-corruption compliance programs, and represented numerous companies in related government investigations.